Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BioIntelliSense Inc.

https://biointellisense.com/

Latest From BioIntelliSense Inc.

HLTH 2022 Roundup: CEOs Of BD And Google Cloud On Innovation, Interoperability, AI

In this second roundup of HLTH, which drew more than 9,000 attendees to Las Vegas from 13-16 November, Medtech Insight highlights presentations from the CEOs of BD and Google Cloud and insights from an interview with BD’s CEO Tom Polen.

Digital Health Innovation

Silicon Valley Bank Advisor Predicts 2022 Will Be Year For Healthtech, Massive Consolidation

SVB health care advisor Jonathan Norris anticipates more consolidation in devices ahead with many mid-cap public companies looking to acquire innovative technologies to grow, and pushing the “big guys to have to figure out how to move faster.”

Financing M & A

Top 10 Start-Up Spotlight Stories In 2020: Theradaptive’s ‘Bone Paint,’ BioIntelliSense’s BioButton, Heart Tech, Portable Ultrasound, Digital Health

A look back at Medtech Insight’s 10 most-read Start-Up Spotlight stories in 2020 pointed to diverse interest among our readers focusing on orthopedics, innovations in cardiac surgery, portable ultrasound tech and digital tools for tracking vital signs and monitoring patients at home.

Start-Up Spotlight StartUps and SMEs
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
    • Monitoring Equipment & Devices
UsernamePublicRestriction

Register